title: [Composites of peptide nucleic acids with titanium dioxide nanoparticles. III. Kinetics of PNA dissociation from nanocomposites containing DNA/PNA duplexes].
abstract: When delivering peptide nucleic acids (PNA) to the cells in the nanocomposites TiO2 · PL · DNA/PNA, containing titanium dioxide nanoparticles coated with polylysine (PL) and immobilized DNA/PNA duplexes, it is important not only to transport them to the cell, but also ability to control the release rate of the PNA-drug from the carrier. PNA desorption from TiO2 · PL · DNA/PNA nanocomposite in time has been shown. Desorption is caused by dissociation of immobilized DNA/PNA duplex while the DNA remains on the carrier and PNA goes away in solution. It has been found that the half-retention times of PNA on TiO2 · PL · DNA/PNA nanocomposites containing DNA/PNA duplexes with overlapping complementary base pairs equal to 10, 12, 14, and 16 are 10, 14, 22 and 70 minutes, respectively. Thus, it has been shown that the release rate of the PNA-drug from nanocomposites can be adjusted by varying the overlap of complementary base pairs in the immobilized DNA/PNA duplex. This method of PNA immobilization may be used for designing of nanocomposites with optimum release time of the PNA-drugs. Created TiO2 · PL · DNA/PNA nanocomposites can be used to efficiently deliver therapeutically significant drug PNA and their selective effect on the pathogenic nucleic acid in the cell.
authors.forename: R N
authors.initials: RN
authors.lastname: Amirkhanov
authors.forename: V F
authors.initials: VF
authors.lastname: Zarytova
authors.forename: N V
authors.initials: NV
authors.lastname: Amirkhanov
mesh_terms: D004247:DNA / Q000737:chemistry; D016503:Drug Delivery Systems; D006801:Humans; D007700:Kinetics; D053761:Nanocomposites / Q000737:chemistry; D053758:Nanoparticles / Q000737:chemistry* / Q000627:therapeutic use; D009692:Nucleic Acid Heteroduplexes / Q000737:chemistry; D020135:Peptide Nucleic Acids / Q000737:chemistry* / Q000627:therapeutic use; D011107:Polylysine / Q000737:chemistry / Q000627:therapeutic use; D014025:Titanium / Q000737:chemistry* / Q000627:therapeutic use
chemical_list: D009692:Nucleic Acid Heteroduplexes; D020135:Peptide Nucleic Acids; C009495:titanium dioxide; D011107:Polylysine; D004247:DNA; D014025:Titanium